JosephABosciaIIIMDFCCP, CPI

Pulmonology • Spartanburg, SC

Critical Care Medicine, Interventional Pulmonology, Pleural Disease

Physician

Join to view full profile

Dr. Boscia is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Boscia's full profile

Already have an account?

Office
151 Harold Fleming Ct
Spartanburg, SC 29303
Phone+1 864-573-6320

Fax+1 864-573-6323

Education & Training

University of RochesterFellowship, Pulmonary Disease and Critical Care Medicine, 1996 - 1999
Berkshire Medical CenterResidency, Internal Medicine, 1993 - 1996
New York Medical CollegeMD, 1992 - 1993
Universidad Autonoma de GuadalajaraClass of 1989

Certifications & Licensure

FL State Medical License 2016 - 2025
NC State Medical License 2015 - 2025
NY State Medical License 1996 - 2025
SC State Medical License 2001 - 2025
American Board of Internal Medicine Critical Care Medicine
American Board of Internal Medicine Pulmonary Disease
National Board of Physicians and Surgeons Critical Care Medicine
National Board of Physicians and Surgeons Internal Medicine
National Board of Physicians and Surgeons Pulmonary Disease

Awards, Honors, & Recognition

Meaningful Use Stage 1 Certification Centers for Medicare & Medicaid Services, 2011

Publications & Presentations

PubMed

414 citations
Bamlanivimab plus Etesevimab in Mild or Moderate Covid-19.
Michael Dougan, Ajay Nirula, Masoud Azizad, Bharat Mocherla, Robert L. Gottlieb
The New England Journal of Medicine. 2021-07-14
83 citations
Fluticasone furoate/vilanterol (100/25; 200/25 μg) improves lung function in COPD: A randomised trial
Fernando J. Martinez, Joseph Boscia, Gregory Feldman, Catherine Scott-Wilson, Sally Kilbride
Respiratory Medicine. 2013-04-01
840 citations
SARS-CoV-2 Neutralizing Antibody LY-CoV555 in Outpatients with Covid-19.
Peter Chen, Ajay Nirula, Barry Heller, Robert L. Gottlieb, Joseph Boscia
The New England Journal of Medicine. 2021-01-21

Journal Articles

SARS-CoV-2 Neutralizing Antibody LY-CoV555 in Outpatients with Covid-19
Robert L Gottlieb, Joseph Boscia, Gregory Huhn, Valentina Stosor, Imad Shawa, The New England Journal of Medicine
SARS-CoV-2 Neutralizing Antibody LY-CoV555 in Outpatients with Covid-19
Robert L Gottlieb, Joseph Boscia, Gregory Huhn, Valentina Stosor, Imad Shawa, The New England Journal of Medicine